Raghavan, A., Plagens, R. N., Ma, C. X., Weber, J. D., Mabry, A., Graff, S. L., Lustberg, M. B., Elliott, A., Sledge, G. W., Osborne, C. K., Rimawi, M., Elkhanany, A., Schiff, R. (2026). <i>TP53</i>
                    status and licensing complex/IFNγ transcriptional profiles to stratify endocrine-related outcomes with CDK4/6i exposure in 10,833 real-world ER+/HER2- breast cancers and a treatment-naïve subset.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1032